Citius Pharmaceuticals is trading 7.3% up at $0.57 in after-hours, with no clear company-specific announcement identified to explain the move. - It closed the regular session at $0.53, following a sharp rebound after a 4.24% decline during the September 30 session. - The latest company news found was a September investor-conference announcement, not a fresh catalyst for September 30. - Broader market data was mixed and does not clearly explain the stock-specific after-hours gain.